A comparison of post-authorization adverse events of biopharmaceuticals and small molecules within the same anatomical therapeutic chemical class
- Huub Schellekens (Invited speaker)
Activity: Talk or presentation › Invited talk › Popular
Activity: Talk or presentation › Invited talk › Popular